EV/EBITDA
-8.68
-0.91-11.71%
Wed, 27 Nov 2024 22:27:57 GMT
Summary:
Inhibikase Therapeutics EV/EBITDA is currently -8.68, with a fall of -0.91 (-11.71%) during the most recent trading day. Over the past year, it has dropped by -9.14 (-1986.96%). IKT EV/EBITDA is now -805.69% below its all-time high of 1.23.IKT EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -11.7% |
| 1 m1 month | -9.6% |
| 3 m3 months | -2070.0% |
| 6 m6 months | -1235.4% |
| ytdytd | -10000.0% |
| 1 y1 year | -1987.0% |
| 5 y5 years | - |
IKT EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -6.57 | -32.1% | -10.02 | +13.4% |
| 3 m | 3 months | -0.30 | -2793.3% | -10.02 | +13.4% |
| 6 m | 6 months | -0.28 | -3000.0% | -10.02 | +13.4% |
| 1 y | 1 year | 0.46 | -1987.0% | -10.02 | +13.4% |
| 3 y | 3 years | 1.23 | -805.7% | -10.02 | +13.4% |
| 5 y | 5 years | 1.23 | -805.7% | -49.12 | +82.3% |
| alltime | all time | 1.23 | -805.7% | -49.12 | +82.3% |
Inhibikase Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -8.68(<-9900.0%) |
| 2023 | 0.06(-118.8%) |
| Date | Value |
|---|---|
| 2022 | -0.32(-233.3%) |
| 2021 | 0.24(-101.2%) |
| 2020 | -19.77 |
FAQ
- What is Inhibikase Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Inhibikase Therapeutics?
- What is IKT EV/EBITDA year-to-date change?
- What is Inhibikase Therapeutics EV/EBITDA year-on-year change?
What is Inhibikase Therapeutics EV/EBITDA?
The current EV/EBITDA of IKT is -8.68
What is the all time high EV/EBITDA for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high EV/EBITDA is 1.23
What is IKT EV/EBITDA year-to-date change?
Inhibikase Therapeutics EV/EBITDA has changed by -8.74 (-14566.67%) since the beginning of the year
What is Inhibikase Therapeutics EV/EBITDA year-on-year change?
Over the past year, IKT EV/EBITDA has changed by -9.14 (-1986.96%)